For example, in an analysis conducted within the Women’s Health Initiative Observational Study, higher fasting insulin levels were associated with greater breast cancer risk [4], however, other studies which measured C-peptide levels as a marker of insulin secretion, often in non-fasting bloods, have generally reported null relationships [5,6]. The gene discussed is INS; the disease is breast cancer.